» Articles » PMID: 38836035

What Can Go Wrong in the Non-coding Genome and How to Interpret Whole Genome Sequencing Data

Overview
Journal Med Genet
Publisher De Gruyter
Specialties Genetics
Medical Ethics
Date 2024 Jun 5
PMID 38836035
Authors
Affiliations
Soon will be listed here.
Abstract

Whole exome sequencing discovers causative mutations in less than 50 % of rare disease patients, suggesting the presence of additional mutations in the non-coding genome. So far, non-coding mutations have been identified in less than 0.2 % of individuals with genetic diseases listed in the ClinVar database and exhibit highly diverse molecular mechanisms. In contrast to our capability to sequence the whole genome, our ability to discover and functionally confirm such non-coding mutations is lagging behind severely. We discuss the problems and present examples of confirmed mutations in deep intronic sequences, non-coding triplet repeats, enhancers, and larger structural variants and highlight their proposed disease mechanisms. Finally, we discuss the type of data that would be required to establish non-coding mutation detection in routine diagnostics.

Citing Articles

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration.

Kurtovic-Kozaric A, Singer-Berk M, Wood J, Evangelista E, Panwala L, Hope A Orphanet J Rare Dis. 2024; 19(1):388.

PMID: 39425167 PMC: 11489993. DOI: 10.1186/s13023-024-03275-x.


Utility of genome sequencing in exome-negative pediatric patients with neurodevelopmental phenotypes.

Nomakuchi T, Teferedegn E, Li D, Muirhead K, Dubbs H, Leonard J Am J Med Genet A. 2024; 194(12):e63817.

PMID: 39031459 PMC: 11540733. DOI: 10.1002/ajmg.a.63817.


Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.

Brlek P, Bulic L, Bracic M, Projic P, Skaro V, Shah N Cells. 2024; 13(6.

PMID: 38534348 PMC: 10969765. DOI: 10.3390/cells13060504.


Systematic assays and resources for the functional annotation of non-coding variants.

Kircher M, Ludwig K Med Genet. 2023; 34(4):275-286.

PMID: 37034418 PMC: 10081529. DOI: 10.1515/medgen-2022-2161.


POSTRE: a tool to predict the pathological effects of human structural variants.

Sanchez-Gaya V, Rada-Iglesias A Nucleic Acids Res. 2023; 51(9):e54.

PMID: 36999617 PMC: 10201441. DOI: 10.1093/nar/gkad225.


References
1.
La Spada A, Taylor J . Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet. 2010; 11(4):247-58. PMC: 4704680. DOI: 10.1038/nrg2748. View

2.
Farwell K, Shahmirzadi L, El-Khechen D, Powis Z, Chao E, Davis B . Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med. 2014; 17(7):578-86. DOI: 10.1038/gim.2014.154. View

3.
Lupski J, Slaugenhaupt S, Pentao L, Guzzetta V, Trask B, Saucedo-Cardenas O . DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 1991; 66(2):219-32. DOI: 10.1016/0092-8674(91)90613-4. View

4.
Neveling K, Feenstra I, Gilissen C, Hoefsloot L, Kamsteeg E, Mensenkamp A . A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat. 2013; 34(12):1721-6. DOI: 10.1002/humu.22450. View

5.
Sellick G, Barker K, Stolte-Dijkstra I, Fleischmann C, Coleman R, Garrett C . Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet. 2004; 36(12):1301-5. DOI: 10.1038/ng1475. View